Possis
This article was originally published in The Gray Sheet
Executive Summary
Firm commences TIME 1 trial for ischemic stroke using AngioJet Rheolytic thrombectomy system, including the AngioJet NV150 catheter. The 30-patient trial is being conducted at six U.S. sites and should be complete in one year